Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01463007 · ClinicalTrials.gov registry record · NA
Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer
A NA study of Breast Cancer, sponsored by Jaroslaw Hepel.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 4
- Study locations
NCT01463007: Completed NA study of Breast Cancer, sponsored by Jaroslaw Hepel.
NCT01463007 is a NA study of Breast Cancer that has completed, run by Jaroslaw Hepel. The registered enrollment target is 40 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01463007, a NA study of Breast Cancer, has completed, sponsored by Jaroslaw Hepel.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the rate of early and intermediate toxicity related to the AccuBoost System for delivery of APBI in women with resected, early stage breast cancer.
Conditions Studied
Interventions
- RADIATION Accelerated partial breast irradiation
- OTHER Extended Follow up
Study Locations (4)
Rhode Island
- Brown University Oncology Research Group - Providence
- Lifespan Hospitals - Providence
Florida
- Center For Cancer Care and Research- Watson Clinic - Lakeland
Washington
- Tacoma Radiation - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-08 |
| Est. Completion | 2021-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01463007
The ClinicalTrials.gov registry entry for NCT01463007 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Jaroslaw Hepel, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Accelerated partial breast irradiation is the first listed.
NCT01463007 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Rhode Island, Florida, Washington.
Frequently Asked Questions
What is clinical trial NCT01463007 about?
NCT01463007 is a clinical study titled "Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer". The purpose of this study is to evaluate the rate of early and intermediate toxicity related to the AccuBoost System for delivery of APBI in women with resected, early stage breast cancer.
What is the current status of trial NCT01463007?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2011-08. Estimated completion is 2021-04-06.
What conditions does trial NCT01463007 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01463007?
The interventions under investigation include: Accelerated partial breast irradiation (RADIATION), Extended Follow up (OTHER).
Who is sponsoring clinical trial NCT01463007?
This trial is sponsored by Jaroslaw Hepel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01463007 being conducted?
This trial has 4 study locations across Florida, Rhode Island, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.